Moreover, a subgroup analysis specifically focusing on breast cancer patients demonstrated a significant association between CD155 expression and decreased OS (pooled HR = 2.137, 95%CI = 1.448–3.154, p < 0.001). This evidence concerns the gene PVR and breast carcinoma.